Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

By Boku Narikazu   Muro Kei   Machida Nozomu   Hashigaki Satoshi   Kimura Nobuyuki   Suzuki Mie   Lechuga Mariajose   Miyata Yoshinori  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite

Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

By Kang Byung  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1671-1675

Springer Publishing Company

Access to resources Recommend Favorite

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer

By Kong Sun-Young   Lim Hyeong-Seok   Nam Byung-Ho   Kook Myeong-Cherl   Kim Young-Woo   Won Ryu Keun   Lee Jun Ho   Choi Il Ju   Lee Jin Soo   Park Young-Iee   Kim Noe Kyeong   Park Sook Ryun  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1147-1155

Future Medicine

Access to resources Recommend Favorite

The widespread use of adjuvant therapy, mainly anthracyclines, over the last 10 years is effective for recurrence in patients with early breast cancer

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Adjuvant medical therapy for prostate cancer

By Sumey Christopher   Flaig Thomas W  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 73-84

Informa Healthcare

Access to resources Recommend Favorite